# Pharmacokinetic Study of Patients Who Undergo Cycloserine, a 2nd-line Antituberculosis Medicament

> **NCT01002170** · — · COMPLETED · sponsor: **Taipei Medical University WanFang Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Pulmonary Tuberculosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01002170
- **Lead sponsor:** Taipei Medical University WanFang Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2009-06
- **Final completion:** 2010-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2010-11-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01002170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01002170, "Pharmacokinetic Study of Patients Who Undergo Cycloserine, a 2nd-line Antituberculosis Medicament". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01002170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*